![1]()
News
Novel inflammatory syndrome in children possibly linked to COVID-19
May 8, 2020
Although cases of the Kawasaki-like symptoms are rare, health authorities advise any children presenting with the symptoms be taken immediately to see a specialist.
![1]()
Opinion
Volunteering during the pandemic: What doctors need to know
May 8, 2020
Just as others helped me achieve my goal of volunteering, I hope I can guide those who would like to do similar work by sharing details about my experience and other information I have collected about volunteering.
![1]()
News
Pandemic-related stress rising among ICU clinicians
May 7, 2020
Most survey respondents “are taking special measures to limit the potential spread of the virus to their loved ones.”
News
COVID-19: Eight steps for getting ready to see patients again
May 7, 2020
You may need to hire temporary workers if your staff tests positive.
News
More guidance on inpatient management of blood glucose in COVID-19
May 7, 2020
Diabetes UK’s COVID-19 task force addresses inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when IVs are unavailable.
News
Results from 11 AHA-funded COVID-19 studies expected within months
May 7, 2020
The AHA’s COVID-19 and Its Cardiovascular Impact Rapid Response Grant initiative awards $1.2 million in grants.
![1]()
News
COVID-19–associated coagulopathy
May 7, 2020
Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.
![1]()
News
IV-to-oral antibiotics can benefit patients with MRSA bloodstream infection
May 7, 2020
Is sequential IV-to-oral antibiotic therapy as effective as outpatient parenteral antibiotic therapy (OPAT) in patients with MRSA BSI?
News
COVID-19 pulmonary severity ascribed to coagulation differences
May 6, 2020
Higher mortality risk among whites with severe COVID-19 infections may be linked to higher propensity for thromboembolism than Chinese patients.
News
New angiotensin studies in COVID-19 give more reassurance
May 6, 2020
A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes.
